Bitrobius Genetics logo

Bitrobius Genetics

Developing the Gentrafix platform technology to revolutionise gene therapy.

6 employees · est. 2020 · Macclesfield, United Kingdom

VS
Certa Therapeutics logo

Certa Therapeutics

Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases

10 employees · est. 2018

Certa Therapeutics is the older company (2020 vs 2018).

Side-by-Side Comparison

Bitrobius Genetics Certa Therapeutics
Founded
2020 2018 older
Headquarters
Macclesfield, United Kingdom Not tracked yet
Employees
6 10
Industry
Biotechnology, Health Care Biotechnology, Health and Wellness
Funding Stage
Series A Grant
Total Funding
Not tracked yet $25.00M
Funding Rounds
1 1
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Gene Therapy, DNA Transfer Technology, Genetic Diseases, Cancer Therapy, Biomedical Engineering Precision Therapy, Inflammatory Diseases, Fibrotic Diseases, Drug Development, Therapeutics, Innovation, Medical Research, Precision Treatment, Biopharmaceutical, Life Sciences, Precision Medicine
Website
bitrobius.com certatherapeutics.com
Bitrobius Genetics logo

About Bitrobius Genetics

Bitrobius Genetics is a biotechnology startup, founded in 2020, with a passionate vision of utilizing the Gentrafix™ platform to revolutionize gene therapy. The company's slogan, "Developing the Gentrafix platform technology to revolutionise gene therapy," underscores its commitment to addressing a...

Certa Therapeutics logo

About Certa Therapeutics

Certa Therapeutics is a biotechnology startup founded in 2018 with a focus on developing innovative precision treatments for inflammatory and fibrotic diseases. The company's slogan, "Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases," reflects its mis...

We will tell you when either one moves

BounceWatch watches Bitrobius Genetics and Certa Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Bitrobius Genetics and Certa Therapeutics — by email.

Frequently Asked Questions

Bitrobius Genetics — Developing the Gentrafix platform technology to revolutionise gene therapy.. Certa Therapeutics — Developing innovative precision therapies for the treatment of inflammatory and fibrotic diseases . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Bitrobius Genetics has raised undisclosed funding while Certa Therapeutics has raised $25.00M.
Bitrobius Genetics and Certa Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Bitrobius Genetics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Bitrobius Genetics on 20 Dec 2024, and Certa Therapeutics on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy